PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Intensive Care Unit, Geneva University Hospitals, Geneva, Switzerland.\', \'Faculty of Medicine, University of Geneva, Geneva, Switzerland.\', \'Geneva Hemodynamic Research Group, Geneva, Switzerland.\', \'Laboratory of Nephrology, Department of Medicine, University Hospitals of Geneva, Geneva, Switzerland.\', \'Department of Cell Physiology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.\', \'Intensive Care Unit, Réseau Hospitalier Neuchâtelois, Site de Pourtalès, Neuchatel, Switzerland.\', \'Intensive Care Unit, Groupement Hospitalier de l\'Ouest Lémanique, Hôpital de zone de Nyon, Nyon, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.14814/phy2.14715
?:doi
?:hasPublicationType
?:journal
  • Physiological reports
is ?:pmid of
?:pmid
?:pmid
  • 33527751
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.948
?:rankingScore_hIndex
  • 19
is ?:relation_isRelatedTo_publication of
?:title
  • Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all